Search

Search Constraints

You searched for: Author/Creator Wappenschmidt, Barbara

Search Results

1. A BRCA1 promoter variant (rs11655505) and breast cancer risk. Issue 4 (22nd April 2010)

2. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. Issue 1 (December 2015)

3. Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia‐like phenotype, and no chromosome fragility. Issue 9 (25th July 2019)

4. BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk. Issue 8 (12th August 2012)

5. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores. (28th July 2021)

6. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants. Issue 14 (10th May 2022)

7. Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points‐based ACMG/AMP approach. Issue 12 (23rd October 2022)

8. Comparison of mRNA Splicing Assay Protocols across Multiple Laboratories: Recommendations for Best Practice in Standardized Clinical Testing. (1st February 2014)

9. DNA methylation array analyses identified breast cancer‐associated HYAL2 methylation in peripheral blood. Issue 8 (24th September 2014)

10. Gene panel testing of 5589 BRCA1/2‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. (9th March 2018)